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ABSTRACT 
Background Individuals of South Asian origin have a high risk of type 2 diabetes (diabetes) and of deaths 
attributable to diabetes. Lifestyle modification intervention trials to prevent type 2 diabetes in high-risk South 
Asian adults have suggested more modest effects than in European origin populations. The strength of the 
evidence of individual studies is limited, however.  
Aim We performed an individual participant data meta-analysis of available randomised controlled trials (RCTs) to 
assess the effectiveness of lifestyle modification in South Asian populations worldwide.   
Methods We searched PubMed, Embase, Cochrane Library and Web of Science (to September 24th 2018) for 
randomised controlled trials on lifestyle modification interventions incorporating diet and/or physical activity in 
South Asian adults. Reviewers identified eligible studies and assessed the quality of the evidence. We obtained 
individual participant data on 1816 participants from all six eligible trials (four from Europe and two from India). 
We generated hazard ratio estimates for incident diabetes (primary outcome) and mean differences for fasting 
glucose, 2-hour glucose, weight, and waist circumference (secondary outcomes), using mixed effect meta-analysis 
overall, and by pre-specified subgroups. We used GRADE to rate the quality of evidence of the estimates. The 
study is registered as PROSPERO: CRD42017078003 
Results Incident diabetes was observed in 12.6% of participants in the intervention groups and in 20.0% of 
participants in the control groups. The pooled hazard ratio for diabetes incidence was 0.65 (95% CI 0.51 to 0.81; 
I2=0%) in intervention compared with control groups. The absolute risk reduction was 7.4% (95% CI 4.0-10.2), with 
no interactions for the pre-specified subgroups (sex, BMI, age, study duration, and region where studies were 
performed). The quality of evidence was rated as moderate. Mean difference for lifestyle modification versus 
control groups for 2-hour glucose was -0.34 mmol/l (95% CI -0.62 to -0.07; I2=51%); for weight -0.75 kg (95% CI -
1.34 to -0.17; I2=72%) and for waist -1.16 cm (95% CI -2.16 to -0.16; I2=74%). No effect was found for fasting 
glucose. Findings were similar across subgroups, except for weight for European versus Indian studies (-1.10 kg 
versus -0.08 kg, p=0.02 for interaction).  
Conclusions/interpretation Despite modest changes for adiposity, lifestyle modification interventions in high-risk 
South Asian populations resulted in a clinically important 35% relative reduction in diabetes incidence, consistent 
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across subgroups. If implemented on a large scale, lifestyle modification interventions in high-risk South Asian 
populations in Europe will reduce the incidence of diabetes in these populations. 
 
Key words: Individual participant data meta-analysis, diet, physical activity, lifestyle intervention, prevention, 
randomised controlled trials, type 2 diabetes, South Asians  
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Research in context summary   
What is already known on this subject?  
• Individuals of South Asian origin have a substantially higher risk of type 2 diabetes (diabetes) and a higher 
proportion of deaths attributable to diabetes than individuals of European origin.  
• Lifestyle modification has been found to be effective in preventing diabetes in European-origin 
populations.  
• Diabetes prevention trials among South Asian adults seem to be less effective than in other populations. 
What is the key question?  
• Do lifestyle modification interventions prevent diabetes in South Asian adults?  
What are the new findings?  
• This systematic review and individual participant data meta-analysis changes our thinking on the assumed 
limited effect of lifestyle modification interventions in high-risk South Asian individuals; we found 
evidence of a meaningful 35% relative reduction and a 7.4% absolute reduction in diabetes incidence 
among South Asian origin people receiving lifestyle modification interventions as compared with controls.  
• Effects were consistent for all a priori pre-specified subgroups.  
• Modest effects were found for 2-hour glucose, weight, and waist circumference, consistent across all pre-
specified subgroups, except for weight by region.  
 
How might this impact on clinical practice in the foreseeable future  
• Given the substantial and growing burden of diabetes, particularly in South Asian origin populations, this 
meta-analysis strongly supports the importance of lifestyle modification interventions as part of a strategy 
to prevent diabetes in these populations.  
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Introduction  
Type 2 diabetes (diabetes) and its complications constitute a major threat to global health. Populations of South 
Asian origin have at least a two to four times higher risk than European origin populations [1, 2] and develop 
diabetes and its complications at a younger age [3, 4]. Patterns of fat deposition, low lean mass [5], and low birth 
weight [6], are considered to contribute to early-onset insulin resistance and diabetes in South Asians, exacerbated 
by changing lifestyle, urbanization and migration. Further, the proportion of deaths attributable to diabetes is 
almost 50% higher in South Asians than in populations of European origin, with no clear signs that the risk will level 
off over time [7]. Therefore, adequate actions for prevention of diabetes among South Asians are imperative.  
From 2001, efficacy trials have documented up to 58% reduction in diabetes incidence in high-risk adults 
through lifestyle modification interventions incorporating a healthy diet and/or physical activity [8-12]. Recent 
meta-analyses of efficacy and pragmatic diabetes prevention trials found a 30-40% reduction in diabetes incidence 
[13, 14]. However, none of these meta-analyses reported effects specifically for South Asians [13, 14], although 
several lifestyle interventions trials have been developed and tested, culturally adapted to suit the specific needs, 
cultural norms and values of the South Asian populations in different contexts [15-18]. Although some trials 
appeared moderately successful, effectiveness differed across studies. Although a few previous reviews have 
explored effects of lifestyle modification interventions on glucose measures and anthropometric outcomes in 
South Asians [19], many were narrative and limited by inconsistent outcome reporting, and none reported 
estimates for diabetes incidence [20]. Due to small numbers in individual studies and low power, either because of 
an a priori too optimistic estimation of effects, or due to drop-out, or lower incidences than expected, the strength 
of the evidence of individual studies is therefore limited, and the further exploration of effects (e.g. subgroup 
analyses) are hampered.  
Given the current knowledge gap about the effectiveness of lifestyle modification interventions in this 
high-risk population, we aimed to assess the overall effect from randomised controlled trials with lifestyle 
interventions with dietary modification and/or physical activity to prevent diabetes in adult South Asians, using 
individual participant data meta-analysis [21]. In addition, we explored if the effects differed by sex, BMI, age, 
study duration, and study region. 
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Methods  
The plan for this individual participant data meta-analysis was registered with the International Prospective 
Register of Systematic reviews (PROSPERO registration CRD42017078003). The reporting is in line with The 
Preferred Reporting Items for Systematic reviews and Meta-Analysis of Individual Participant Data [22].  
 
Eligibility criteria We included randomised controlled trials that compared the effect of lifestyle modification 
interventions incorporating a healthy diet and/or physical activity with usual care/control groups not receiving the 
lifestyle intervention to prevent diabetes in the South Asian adult population (≥18 years) worldwide. To reduce the 
risk of bias in the estimates, studies were only included if judged to be at least of moderate quality by the Quality 
Assessment Tool for Quantitative Studies (see below) [23]. We a priori decided to exclude studies exclusively on 
drugs and surgical interventions, alone, or in combination with lifestyle modification, or evaluating physical activity 
components not consisting of cardio-vascular exercise (e.g., yoga) as the only physical activity component, or single 
dietary components (such as vitamin D supplementation). 
 
Search strategy We searched PubMed, Embase, Cochrane Library and Web of Science, first from the start to  
September 30th 2017 to allow for inclusion of studies for the individual participant data meta-analysis (search 
strategy: Electronic supplementary material (ESM)), supplemented with reference list tracing of key reviews [19, 
20, 24, 25], included studies [12, 15-18, 26], and by searching trial registers. The search was updated on September 
24th 2018. The work builds on and complements our previous narrative systematic review of dietary and physical 
activity components recommended in experimental, quasi-experimental and before-after studies to prevent 
diabetes in South Asians [27].  
 
Study selection and risk of bias assessment Two reviewers independently screened titles and abstracts for 
eligibility, thereafter full-texts. The risk of bias was assessed at the study level using the Quality Assessment Tool 
for Quantitative Studies [23] by three reviewers as we perceived the quality assessment tool to be vulnerable to 
differences in interpretation. For all processes, a discussion was held in case of discrepancies to reach consensus. 
Only studies judged to be at least of moderate quality were included [23].  
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Data extraction Information on study design and population characteristics was extracted from published 
manuscripts, study protocols, and personal communication with authors, using a piloted extraction form, by two 
reviewers working independently [27]. A discussion was held in case of discrepancies, and a third independent 
reviewer arbitrated, if necessary. Principal investigators of eligible studies published prior to September 30th 2017 
were contacted for permission to include individual participant data on sex, age, anthropometric measures, and 
fasting, and 2-hour glucose, from oral glucose tolerance tests. To allow for transformation and analysis, the 
deadline for data inclusion was set to March 1st 2018. After ethical approval for this study from each primary study, 
data transfer agreements were signed before we received anonymized individual level data.  
 
Data analysis and quality of the evidence The primary outcome was diabetes incidence, defined as fasting glucose 
≥ 7.0 mmol/l, and/or 2 hour-glucose ≥ 11.1mmol/l, or registered as doctor diagnosed by self-report at follow-up 
visits [12, 16, 26]. Secondary intermediate outcomes were changes in fasting glucose, 2 hour-glucose, body weight 
(kg), and waist circumference (cm). Except for one study with age stratified into nine groups [16], we used age in 
years. Analyses were based on an intention-to-treat approach. All principal investigators confirmed preliminary 
analyses after variable standardization and data cleaning. 
Cox proportional hazards models were used to estimate age-adjusted hazard ratios of diabetes incidence. 
The proportional hazard assumption was tested separately for each covariate and also overall (global test) and 
found to be met. The three studies with men and women were also adjusted for sex. Time to diabetes was used as 
the dependent variable in our survival analysis, and calculated from the trial start date to either the diabetes 
diagnosis, or the end of each trial. For secondary outcomes, we determined mean differences with 95% CIs, 
adjusted for baseline values for the outcome variable of interest, age, and sex when relevant, using the last 
available estimate [21]. Individual participant data meta-analyses were done in two stages. First, mixed regression 
models with random effects at individual level and group allocation as fixed-effect were performed for each study. 
For secondary outcomes, we used generalized linear models with identity link function for studies with only one 
follow-up visit [17, 18]. Secondly, estimates from the multilevel models were used to estimate weighted averages 
across studies. We used the I-squared statistics to express the amount of variance attributable to study 
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heterogeneity. A priori defined subgroup analyses were performed for sex, baseline BMI ≥ 27.5 kg/m2 or below, 
age > 44 years or below, short (5-7 months) and long-term (2-3 years) study duration, and region, testing for 
interactions between subgroups. We used Stata version 15.1 for the regression analyses for each study, and to 
generate weighted estimates across studies, and the metafor package in R for the forest plots. Due to loss to 
follow-up in some studies, we performed a sensitivity analysis applying within-trial multiple imputations [28]. In 
trials with multiple follow-up visits [15, 16, 26] we used REALCOM-IMPUTE [29] to account for correlation between 
repeated measures. In trials with one follow-up [17, 18] we used the Multiple Imputation by Chained Equations 
[30]. For each trial, we created 20 imputed datasets, thereafter combined for pooled estimates. We also 
performed funnel plots to visually explore possible publication bias/small study effect.  
Finally, we used the GRADE approach to rate the quality of evidence and to generate absolute effect 
estimates for the outcomes [31]. In our previous systematic review, we identified randomized controlled trials that 
ended until 2015 and had not published results or updated their registrations [27]. Of the six that were identified 
and that might have been eligible for the individual participant data meta-analysis, three have not yet reported, 
one has since published results [32], and two are still ongoing. Although it is unclear if the underreporting is 
related to unsuccessful inclusion or negative results, it is indicative of a probable publication bias.  
 
Results 
Description of included studies We identified 4240 publications and, after removal of duplicates, 3009 titles and 
abstracts were screened, of which 2983 were excluded (Flow chart; ESM Figure 1). Following full-text review of 17 
articles, six randomized controlled trials fulfilled the inclusion criteria for the individual participant data meta-
analysis [12, 15-18, 26]. Characteristics of excluded studies [32-42] are given in ESM Table 1. We obtained 
individual participant data for all six eligible studies for the meta-analysis (Table 1). When cleaning the data for 
analyses we identified 29 cases from two studies with glucose levels indicative of diabetes at inclusion [17, 18]. 
These cases were excluded, leaving 1816 participants, of whom 604 (33%) were female. Three studies included 
both sexes, two were in males [18, 26], and one in females only [17]. Four studies were of 2-3 years duration [12, 
15, 16, 26], while two lasted 5-7 months [17, 18]. Four studies were from Europe [15-18] and two from India [12, 
26]. Five studies combined a dietary and physical activity intervention [12, 15-17, 26], while one used physical 
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activity only (primarily floorball/field hockey) [18]. Individual and/or group-based educational sessions were 
provided with varying intensity, one supported by mobile phone messages [26]. One study offered home visits 
from a dietitian and involvement of family members [16], three were performed in the community [15, 17, 18], 
and the two Indian studies were performed in a workplace setting [12, 26].  The quality of five studies was rated as 
strong (ESM Table 2).  
Loss to follow-up differed from more than 20% in two studies [15, 17] of 7 months and 2 years duration, 
to 0-2.3% in other studies that had 3 years duration [12, 16] (ESM Table 3). No clear patterns of differences in 
baseline characteristics between the intervention and control groups were observed (ESM Table 4). The age range 
at inclusion was 18-80 years, with mean age differing from 37 [18] to 52 years [16]. The mean BMI differed from 26 
kg/m2 in the Indian studies [12, 26] to 30.6 kg/m2 in one European study [16]. At baseline, mean 2-hour glucose 
levels were highest in the Indian studies, which only included participants with persistently impaired glucose 
tolerance [12, 26].   
 
Diabetes incidence Incident diabetes was observed in 118 of 936 (12.6%) participants in the intervention group 
and in 176 of 880 (20.0%) participants in the control group (adjusted hazard ratio 0.65 (95% CI 0.51 to 0.81; 
p=0.0002, I2=0%) (Table 2 and Figure 1). This reflects an absolute reduction of 7.4% (95% CI 4.0-10.2) and a number 
needed to treat (NNT) of 14 (95% CI 10.0 -28.0). In subgroup analyses, we did not find differences in relative 
estimates of effects by sex, age, BMI, study duration, or region. For the long-term studies, the estimates were 
identical after exclusion of one study [15] with high loss to follow-up (0.65, (95% CI 0.51 to 0.83, p=0.0004)). 
Overall, and for subgroups, we found no (I2=0%), or low, between-study heterogeneity. According to GRADE the 
quality of evidence can be rated as moderate; quality was rated down due to some, but overall limited, concerns of 
risk of bias (e.g. lacking blinding of participants and providers), and possible publication bias, although not 
confirmed by visual inspection of funnel plots (data not shown).  
 
Other outcomes For secondary outcomes, we observed a reduction in 2-hour glucose (-0.34 mmol/l, 95% CI -0.62 
to -0.04; p=0.02, I2=51%), weight (-0.75 kg, 95% CI -1.34 to -0.17; p=0.01, I2=72%), and waist circumference (-1.16 
cm, 95% CI -2.16 to -0.16; p=0.02, I2=74%) in the intervention versus control group (Table 3 and EMS Figure 2), with 
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no effect for fasting glucose (-0.03, 95% CI -0.16 to 0.16, p=0.37, I2=27%). No consistent subgroups differences in 
effects were found for secondary outcomes (ESM Table 5), although a difference in effect for weight (-1.10 kg 
versus -0.08 kg, p=0.02 for interaction) was revealed for European versus Indian studies, with a similar but non-
significant effect estimate for waist circumference (-1.59 cm vs -0.26 cm, p=0.09 for interaction). The GRADE 
quality of evidence for 2-hour glucose was rated as moderate, rated down due to some concerns of risk of bias. For 
the other secondary outcomes, the quality was considered low due to imprecision and/or heterogeneity between 
studies (ESM Table 5). Sensitivity analyses after multiple imputations yielded similar effect estimates as the main 
analysis for secondary outcomes, although CIs were slightly wider, and the result for weight was only borderline 
significant (p =0.06; results not shown). Lastly, the distribution curves for fasting and 2-hour glucose at the last visit 
for all studies merged, showed a larger shift to the right in the control than in the intervention group (ESM Figure 
3). In the intervention group, 4.5% had developed diabetes at the last follow-up based on fasting glucose values ≥ 
7.0 mmol/l, and 8.2% based on fasting glucose values ≥ 11.1 mmol/l, compared with 7.5% (p=0.017) and 14.9% (p 
<0.0001) respectively in the control group.  
 
Discussion 
In this individual participant data meta-analysis we found that the overall incidence of diabetes was 
reduced by 35% in the lifestyle modification intervention compared with the control group, with an absolute risk 
reduction of 7.4%, and a number needed to treat of ~14 over a mean of two years. Results for diabetes were 
consistent for males and females and for other key subgroups. The studies included participants with normal and 
impaired glucose regulation and a range of age and BMI values at baseline, indicating high external validity. We 
also found evidence of a modest effect on 2-hour glucose and simple adiposity (weight and waist circumference) 
measures. Of note, however, at the last follow-up we observed both for fasting and 2-hour glucose a stronger shift 
on the right side of the distribution curve in the control groups, with significantly more diabetes cases, compared 
to the intervention groups.  
The main strength of this study is that it is the first to report summary effects of lifestyle interventions on 
diabetes incidence in the high-risk South Asian population. Starting with a systematic review of the literature, we 
used individual participant data meta-analysis from all the six eligible randomized controlled trials among South 
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Asians published prior to the inclusion date, to produce precise summary effects overall and across subgroups [21], 
also for our secondary outcomes fasting and 2-hour glucose and adiposity measures. Compared with meta-
analyses based on aggregate data on study level from published papers, individual participant data meta-analysis 
facilitates standardisation of analyses, increases the precision of estimates and the quality of subgroup analyses 
[21]. Further, assessing the quality of evidence according to GRADE, we systematically and transparently assessed 
all factors that could impact on our certainty in the effects estimates, including risk of bias in each study, 
heterogeneity, indirectness, imprecision, and publication bias [31].  
However, our review is limited by a relatively small number of trials, some with high loss to follow-up, and 
relatively little variation in settings. The included studies counted approximately 300 incident cases of diabetes, 
the majority (83%) from the Indian studies. Thus, the power to detect subgroups differences and to further explore 
between-study heterogeneity for the adiposity measures was limited. Although we consider the evidence to be 
generally applicable to the target population, we cannot fully rule out potential indirectness due to differences 
between populations (country of origin or migrant status), interventions (type, content, intensity, mode of 
delivery, compliance), and settings (family and community-based versus workplace).  
Our meta-analysis included efficacy [12, 16] and more pragmatic trials [15, 17, 18, 26]. The 35% relative 
risk reduction in diabetes incidence resembles the risk reduction (39%) reported in a standard meta-analysis of 19 
efficacy and pragmatic diabetes prevention trials in subjects with impaired glucose tolerance or impaired fasting 
glucose after a mean of 2.6 years active lifestyle intervention [13]. Although ten studies in the latter meta-analysis 
were conducted in Asia, result for South Asians were not reported. Of note, the absolute benefit on diabetes 
prevention was higher in our study than in this meta-analysis (7.4% vs 4.0%. respectively) and so the NNT was 
lower (14 versus 25) [13]. Our findings compare well with the first efficacy studies, reporting 6.2-12% absolute risk 
reductions (NNT 16-8 respectively) [8, 9], but somewhat stronger than in a meta-analysis of translational studies to 
prevent diabetes in high-risk populations other than South Asians (relative risk reduction: 29%, absolute risk 
reduction; 3%) [14].  
Meta-analysis of diabetes prevention trials indicated that dietary and physical activity interventions 
combined were more effective than either strategies alone, but the number of studies was limited for single 
strategy studies [13]. Although more studies to date seems to indicate that the dietary interventions are more 
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effective than physical activity interventions to reduce diabetes incidence in high risk individuals, the potential of 
physical activity interventions may be underestimated due to shortcomings in the type, intensity and mode of 
delivery. Although we could not assess this, the intensity of the interventions in the long-term studies in our 
review was lower [12, 26] or comparable [16] to those of the first efficacy studies which had stronger effects [8, 9]. 
Even a low-cost community-based peer-support lifestyle intervention program published too late to be included in 
our study, found a 12% relative reduction in diabetes incidence in individuals with a high Indian Diabetes Risk Score 
[32]. The smaller effect might be partly attributed to the selection of participants, with the majority having 
normoglycemia or isolated impaired fasting glucose at baseline, as there are no proven interventions so far to 
reduce diabetes incidence in such subjects [32]. 
In contrast to our finding of an overall 35% reduction on diabetes incidence with a relative small mean 
0.75 kg reduction in weight, studies in other populations found weight reduction to be the main driver of the effect 
[8, 9, 13], i.e. 16% reduction in diabetes incidence for each kg of weight loss [43]. Of note, despite small changes in 
mean weight and waist circumference values, both for fasting glucose (primarily reflecting hepatic insulin 
resistance) and 2-hour glucose (reflecting muscle insulin resistance), the intervention had a more profound effect 
on the right side of the distribution curve, indicating a reduced insulin resistance [44]. Further, achievements of 
dietary and physical activity goals, even without weight loss, may improve 2-hour glucose and reduce diabetes 
incidence [8], as found in the Indian studies in our review [12, 26], where a reduction in portion size, consumption 
of carbohydrates and oil intake was related to a lower diabetes incidence even without weight loss [38]. Although 
trials among South Asians are few, there are indications that improvements in the quality of the diet (more 
complex carbohydrates, monounsaturated and polyunsaturated fatty acids) might improve blood glucose, serum 
insulin, lipids, inflammatory markers and hepatic fat [5].   
Although only 33% of participants were females in our meta-analysis, as previous studies were 
underpowered to study potential sex differences, an important new finding was that their diabetes incidence was 
significantly reduced, despite a slightly smaller non-significant effect estimate for 2-hour glucose, weight, and waist 
circumference than in males. Furthermore, the larger effect on weight, with a concomitant non-significant effect 
estimate for waist circumference in the European than in the Indian studies in our meta-analysis is noteworthy. 
This may reflect different phenotypes, as it would be easier to achieve a larger reduction in weight measures 
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amongst South Asians residing in Europe, who had higher BMIs, but differences in the diet and/or physical activity 
level at baseline or induced by the intervention may also be involved. Furthermore, perceptions of weight and 
health are changing across generations, and differ by region [45]. South Asians living in Europe, particularly 
females, may be more sensitized to the importance of weight loss than those living in their country of origin [46]. 
Others report that sex did not influence the effects of lifestyle interventions [13], and lifestyle trials aimed at 
weight loss which explored sex differences in anthropometric outcomes, mostly report stronger effects in males, 
but actual sex differences were small [47]. Thus, there is little evidence yet to indicate that males and females 
generally should adopt different weight loss strategies.  
As the studies outside India in our meta-analysis, conducted mostly among first-generation South Asian 
migrants in Europe, had suggested only a modest effect, comparable and clinically important effects on diabetes 
incidence regardless of region have important implications for policymakers and clinicians. The consistency of 
effects across subgroups of the South Asian population at risk of diabetes has made us rethink, contrary to our 
priori beliefs based on the outcomes of single studies, that benefits actually may be achieved by lifestyle 
modification interventions, not only under ideal conditions, but also in real-life settings [15, 17, 18, 26]. Cultural 
adaptations to mode of delivery may be necessary across contexts as cultural adaptations likely promote the 
effectiveness of interventions among specific ethnic populations [48, 49], although evidence of effects of cultural 
targeting on diabetes prevention outside India is still scarce [50]. Interestingly, one study using a culturally 
targeted physical activity intervention (floorball/field hockey) for men provided strong results for all secondary 
outcomes, although limited by its small size and short duration [18]. 
There are, however, several unanswered questions that should be addressed. First, lifestyle intervention 
studies have used generic recommendations (i.e. based on those for the local majority population) [27], while 
different targets for dietary and physical activity recommendations may be necessary [27, 51]. Further work is 
required on the mechanisms by which these interventions are having their effect, including the role and type of 
physical activity, diet quality, specific dietary components, cooking practices and timing of meals [52]. Further, we 
predict that larger effects on diabetes risk in South Asians might be achieved in studies aiming at larger weight 
reductions [53, 54], and with more intense dietary and physical activity changes [51]. Reach, retention and long-
term sustainability may be enhanced through improvements in targeting and delivery, and benefits in the longer 
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term (beyond two to three years) should be further investigated. Hopefully, ongoing studies will be complemented 
with new high quality trials addressing the issues outlined above. Future systematic reviews should be extended to 
explore effects by mode of delivery, intensity and contextual factors. In addition to high-risk strategies, there are 
strong recommendations for population-based strategies as part of national public health policies [52].  
In conclusion, pending deeper understanding of the causation of diabetes in South Asians, and the 
development of new kinds of interventions, this individual participant data meta-analysis of lifestyle modification 
interventions in South Asian populations at high risk of diabetes provides evidence of a clinically important 35% 
relative reduction in diabetes incidence, with a NNT of 14 to prevent one case of diabetes over a mean of two 
years. Given the substantial and growing burden of diabetes, particularly in South Asian origin populations, this 
meta-analysis provides support for ongoing strategies underpinned by weight loss, dietary change and increased 
physical activity to prevent type 2 diabetes. Future work should aim to understand the mechanisms by which these 
effects occur, evaluate cost effectiveness, and develop more effective interventions.  
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Table 1      Randomized controlled trials included in the individual participant data meta-analysis 
Study ID Countr
y 
Ethnicity Size 
(n) 
Age  
(years) 
Sex 
(% 
men) 
Inclusion 
criteria 
Duration 
(months) 
Mode of delivery of 
intervention 
Components Setting 
         Diet PA  
IDPP-1 
(2006)12 
India Indians 253 35-56 76.3 IGT after 2 
OGTTs 
36 Personal sessions 
every 6 months, 
calls 1 / month 
Based on 
dietary 
guidelines for 
Indians 
30 min brisk 
walking daily 
Workplace 
PAMH 
(2012)18 
Norway Pakistani 139 25-60 100 Not 
regularly 
physically 
active, free 
of diagnosed 
diabetes 
5 Physiologist-led 
group exercise 
session (floorball≠) 
(2x / week), 1x1h 
individually 
counselling session, 
2 group lectures 
and follow-up 
phone call 
No specific 
dietary 
recommendatio
ns 
30 min PA 
daily 
Community 
Innva-
DiabDE-
PLAN 
(2013)17 
Norway Pakistani 180 25-62 0 Free of 
diagnosed 
diabetes or 
CVD 
7 Educational 2-hour 
sessions (6x / 
7months) 
Carbohydrate, 
sugar, whole 
grain, legumes 
and types of fat 
recommendatio
ns 
60 min 2 
days/week 
(5000 steps). 
Walking 
groups. 
Community 
DHIAAN 
(2013)15 
Nether-
lands 
South 
Asian 
Surinames
e 
536 18-60 49.2 IFG or IGT, 
or HbA1c 42-
46 mmol/l, 
or HOMA-IR 
≥2.39 
12/24* Dietitian, 
motivational 
interviewing (8-10x 
/ 1 year), family 
session, cooking 
class, supervised PA 
program 
Fat, fibre, fruit, 
vegetable and 
breakfast 
recommendatio
ns, based on 
national data. 
30 min PA 
daily 
Community 
Indian 
SMS 
Study 
(2013)26 
India Indians 537 35-55 100 BMI≥23 
kg/m2 and 
IGT after 2 
OGTTs 
24 Baseline 
educational 
session, 2-4 mobile 
phone 
messages/week 
Based on 
dietary 
guidelines for 
Indians 
30 min brisk 
walking daily 
Workplace 
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PODOSA 
(2014)16 
Scot-
land 
South 
Asian 
171 35-80 45.6 Waist ≥90 
cm men/ 
≥80 cm 
women and 
IGT or IFG 
36 Dietitian(15 home 
visits over3 years), 
involvement of 
family volunteers, 
annual group 
sessions 
Calorie-deficit 
diet, based on 
Finnish DPS 8 
30 min brisk 
walking daily 
Family/hom
e-based 
*Quality assessment is based on published paper for results after 12 months, but we also have IPD after 24 months. IGT: Impaired glucose, IFG: Impaired fasting 
glucose. OGTT: Oral glucose tolerance ≠  floor ball is close to field hockey/land hockey, but played indoor. 
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Table 2 Diabetes risks overall and within pre-specified subgroups  
 
 
 
Outcome 
No. of 
studies 
All 
cases/N 
Interventio
n 
n/N 
Control 
n/N 
Hazard ratio* 
(95% CI) 
p 
value† 
I2 p value 
interaction
‡ 
Overall   6 294/181
6 
118/936 176/880 0.65 (0.51-0.81) 0.0002 0  
Sex§         
   Males          5 244/121
1 
102/624 142/587 0.68 (0.53-0.88) 0.003 0 0.30 
   Females     4 50/604 16/312 34/292 0.48 (0.26-0.88) 0.02 0  
BMI         
   ≥ 27.5 kg/m2 6 97/729 38/362 59/367 0.64 (0.34-1.20) 0.15 42 0.99 
   <27.5 kg/m2 6 197/108
7 
80/574 117/513 0.64 (0.46-0.88) 0.002 0  
Age         
   >44 years 6 170/946 70/481 100/465 0.69 (0.50-0.93) 0.02 0 0.55 
   ≤ 44 years  6 124/870 48/455 76/415 0.59 (0.41-0.85) 0.005 0  
Study duration        
   5-7 months 2 4/319 2/177 2/142 0.72 (0.10-5.20) 0.74 0 0.92 
   2-3 years 4 290/149
7 
116/759 174/738 0.64 (0.51-0.81) 0.0003 0  
Study region         
   Europe   4 50/1026 21/545 29/481 0.69 (0.39-1.21) 0.19 0 0.81 
   India       2 244/790 97/391 147/399 0.64 (0.49-0.82) 0.0006 0  
* Hazard ratios adjusted for age and sex. † p values for Hazard ratios; ‡ p values for interaction term for 
subgroup analyses  
§ one person in the control group had missing information about sex 
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Table 3   Overall effects of lifestyle interventions (mean difference) on continuous outcomes, pooled data 
with last estimate 
 
Outcome No. of 
studies 
No. of 
Participant
s 
Intervention 
Mean 
(SD) Kg 
Control 
Mean 
(SD) Kg 
Summary 
Adjusted MD* 
(95% CI) 
p 
value† 
I2 (%) 
Fasting glucose 
(mmol/l), last 
estimate 
6 1411 5.5 (0.90) 5.6 (1.15) -0.03 (-0.10, 0.04) 0.37 27 
2-hr glucose 
(mmol/l), last 
estimate 
6 1428 7.4 (2.44) 8.1 (3.09) -0.34 (-0.62, -
0.07) 
0.02 51 
Weight (kg), last 
estimate 
6 1479 73.7 (13.08) 74.1 
(12.44) 
-0.75 (-1.34,-0.17) 0.01 72 
Waist (cm), last 
estimate 
6 1462 93.7 (10.18) 94.5 
(9.73) 
-1.16 (-2.16, -
0.16) 
0.02 74 
*Mean difference based on last estimate (Podosa and IDDP =3 years, DHIAAN and Indian SMS Study= 2 
years, InnvaDiab= 7 months and PAMH= 5 months), adjusted for age and baseline values for outcome 
variable. † p values for mean difference. Analyses are based on participants with at least two 
measurements. Two studies (DHIAAN, InnvaDiab) had >20% missing data at follow-up (similar for 
intervention and control group).   
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Fig. 1 Forest plot of hazard ratios for diabetes in intervention versus control group, overall and for 
subgroups –  will insert year and references for studies + q statistics.  
  
025 
Diabetologia https://doi.org/10.1007/s00125-019-4905-2  (Published online 15 June 2019)   
ELECTRONIC SUPPLEMENTARY MATERIAL (ESM):  
Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: 
individual participant data meta-analysis of randomised controlled trials   
ESM Search strategy 
Pubmed: 
(("Asia, Western"[Mesh:NoExp] OR "Bangladesh"[Mesh] OR "Sri Lanka"[Mesh] OR "Nepal"[Mesh] OR 
"Bhutan"[Mesh] OR "India"[Mesh] OR "Pakistan"[Mesh] OR South Asia*[tiab] OR Asian India*[tiab] OR 
Pakistan*[tiab] OR Bangladesh*[tiab] OR Sri Lanka*[tiab] OR Nepal*[tiab] OR Bhutan*[tiab] OR India*[tiab]) 
AND ("Diabetes Mellitus"[Mesh:NoExp] OR "Diabetes Mellitus, Type 2"[Mesh] OR "Overweight"[Mesh] OR 
"Obesity"[Mesh] OR diabet*[tiab] OR obes*[tiab] OR overweight[tiab] OR weight[tiab]) AND ("Diet"[Mesh]  
OR "Diet Therapy"[Mesh] OR "Eating"[Mesh] OR  "Feeding Behavior"[Mesh:NoExp] OR "Food Habits"[Mesh] 
OR "diet therapy" [Subheading] OR intake[tiab] OR food*[tiab] OR diet*[tiab] OR nutrition*[tiab] OR 
eat*[tiab] OR "Exercise"[Mesh] OR "Exercise Therapy"[Mesh] OR "Physical Fitness"[Mesh]  OR 
"Sports"[Mesh] OR activ*[tiab] OR sport*[tiab] OR exercis*[tiab] OR walk*[tiab] OR lifestyle modification[ti]) 
AND ("Primary Prevention"[Mesh] OR "prevention and control" [Subheading] OR "Guideline" [Publication 
Type] OR guideline* OR intervention*[tiab] OR advice*[tiab] OR recommendation*[tiab] OR prevent*[tiab] 
OR promot*[tiab] OR support*[tiab]) AND ("Clinical Trial" [Publication Type] OR "Clinical Trials as 
Topic"[Mesh] OR "Cohort Studies"[Mesh] OR "Case-Control Studies"[Mesh] OR "Intervention 
Studies"[Mesh] OR "Feasibility Studies"[Mesh] OR "Case Reports" [Publication Type] OR "Clinical 
Conference" [Publication Type] OR "Comparative Study" [Publication Type] OR "Consensus Development 
Conference" [Publication Type] OR "Evaluation Studies" [Publication Type]  OR "Meta-Analysis" [Publication 
Type] OR "Multicenter Study" [Publication Type] OR "Validation Studies" [Publication Type] OR 
"Observational Study" [Publication Type] OR "Pilot Projects"[Mesh] OR "Controlled Before-After 
Studies"[Mesh] OR before after stud*[tiab] OR  trial[ti] OR controlled[ti] OR random*[tiab] OR 
intervention*[tiab] OR cohort*[tiab]  OR compar*[tiab]  OR control*[tiab] OR experimental stud*[tiab])) 
NOT ("Child"[Mesh]  NOT "Adult"[Mesh])  NOT  (("Animals"[Mesh] NOT "Humans"[Mesh]) OR "Animals, 
Laboratory"[Mesh] OR "Animal Experimentation"[Mesh] OR "Models, Animal"[Mesh] OR "Rodentia"[Mesh] 
OR rat[ti] OR rats[ti] OR mouse[ti] OR mice[ti] OR "Editorial" [Publication Type] OR "Letter" [Publication 
Type] OR "News" [Publication Type] OR "Comment" [Publication Type] OR "Historical Article" [Publication 
Type] OR "Anecdotes as Topic"[Mesh] OR letter*[ti] OR comment*[ti] OR abstracts[ti]) 
 
Embase (Ovid): 
# Searches 
1 south asia/ or bangladesh/ or bhutan/ or india/ or nepal/ or pakistan/ or sri lanka/ or (South Asia* 
or Asian India* or Pakistan* or Bangladesh* or Sri Lanka* or Nepal* or Bhutan* or India*).ti,ab,kw. 
2 *diabetes mellitus/ or *non insulin dependent diabetes mellitus/ or exp *obesity/ or (diabet* or 
obes* or overweight or weight).ti,ab,kw. 
3 exp *diet/ or exp *diet therapy/ or *food intake/ or *eating/ or exp *dietary intake/ or exp feeding 
behavior/ or (intake or food* or diet* or nutrition* or eat*).ti,ab,kw. or exp exercise/ or exp 
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*kinesiotherapy/ or *fitness/ or exp *sport/ or physical activity/ or (activ* or sport* or exercis* or 
walk*).ti,ab,kw. or lifestyle modification.ti. 
4 *prevention/ or "prevention and control"/ or primary prevention/ or pc.fs. or exp practice 
guideline/ or (guideline* or intervention* or advice* or recommendation* or prevent* or promot* 
or support*).ti,ab,kw. 
5 exp clinical trial/ or exp controlled clinical trial/ or randomized controlled trial/ or clinical study/ or 
"clinical trial (topic)"/ or exp "randomized controlled trial (topic)"/ or case study/ or clinical study/ 
or cohort analysis/ or retrospective study/ or prospective study/ or exp comparative study/ or exp 
controlled study/ or experimental study/ or observational study/ or prevention study/ or validation 
study/ or "systematic review"/ or multicenter study/ or pilot study/ or (before adj10 (after or 
during)).ti,ab. or (trial or controlled).ti. or random*.ti,ab. or ((experiment* or quasi* or random* or 
control) adj3 (method* or study or trial or design*)).ti,ab,kw. 
6 child/ not adult/ 
7 (animal/ not human/) or (exp experimental animal/ or animal experiment/ or animal model/ or exp 
rodent/ or editorial/ or letter/ or literature/ or (letter* or comment* or abstracts).ti.) 
8 (1 and 2 and 3 and 4 and 5) not 6 not 7 
 
Cochrane library: 
ID Search  
#1 MeSH descriptor: [Asia, Western] this term only 
#2 MeSH descriptor: [Bangladesh] explode all trees 
#3 MeSH descriptor: [Sri Lanka] explode all trees 
#4 MeSH descriptor: [Nepal] explode all trees 
#5 MeSH descriptor: [Bhutan] explode all trees 
#6 MeSH descriptor: [India] explode all trees 
#7 MeSH descriptor: [Pakistan] explode all trees 
#8 South Asia* or Asian India* or Pakistan* or Bangladesh* or Sri Lanka* or Nepal* or Bhutan* or 
India*:ti,ab,kw  (Word variations have been searched) 
#9 MeSH descriptor: [Asia, Western] explode all trees 
#10 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8  
#11 MeSH descriptor: [Diabetes Mellitus] this term only 
#12 MeSH descriptor: [Diabetes Mellitus, Type 2] explode all trees 
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#13 MeSH descriptor: [Overweight] explode all trees 
#14 diabet* or obes* or overweigh*:ti,ab,kw  (Word variations have been searched) 
#15 #11 or #12 or #13 or #14  
#16 MeSH descriptor: [Diet] explode all trees 
#17 MeSH descriptor: [Diet Therapy] explode all trees 
#18 MeSH descriptor: [Eating] explode all trees 
#19 MeSH descriptor: [Feeding Behavior] explode all trees 
#20 intake or food* or diet* or nutrition* or eat*:ti,ab,kw  (Word variations have been searched) 
#21 MeSH descriptor: [Exercise] explode all trees 
#22 MeSH descriptor: [Exercise Therapy] explode all trees 
#23 MeSH descriptor: [Physical Fitness] explode all trees 
#24 MeSH descriptor: [Sports] explode all trees 
#25 MeSH descriptor: [Motor Activity] explode all trees 
#26 MeSH descriptor: [Physical Education and Training] explode all trees 
#27 activ* or sport* or exercis* or walk*:ti,ab,kw  (Word variations have been searched) 
#28 #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27  
#29 MeSH descriptor: [Primary Prevention] explode all trees 
#30 MeSH descriptor: [Guideline] explode all trees 
#31 guideline* or intervention* or advice* or recommendation* or prevent* or promot* or 
support*:ti,ab,kw  (Word variations have been searched) 
#32 MeSH descriptor: [Health Planning Guidelines] explode all trees 
#33 #29 or #30 or #31 or #32  
#34 #10 and #15 and #28 and #33 
 
Web of Science: 
# 5 #4 AND #3 AND #2 AND #1 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
# 4 TITLE: (diabet* OR obes* OR overweight OR weight) 
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Indexes=SCI-EXPANDED, SSCI Timespan=All years 
# 3 TOPIC: (guideline* OR intervention* OR advice* OR recommendation* OR prevent* OR 
promot* OR support*) 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
# 2 TOPIC: (intake OR food* OR diet* OR nutrition* OR eat* OR activ* OR sport* OR exercis* OR 
walk*) 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
# 1 TITLE: (South Asia* OR Asian India* OR Pakistan* OR Bangladesh* OR Sri Lanka* OR Nepal* 
OR Bhutan* OR India*) 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
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ESM Tables  (Must check the formatting of these tables – bold, footnotes etc once more) 
ESM Table 1.  Characteristics of excluded studies 
 
Study ID/ year Study 
design 
Country Ethnicity Age 
(yrs) 
% 
Male 
Target group Sample 
(n) 
Duration* Intervention Reason for 
exclusion 
Mayer-Davis 
(2004)33 
RCT USA Asian 
American 
⩾ 
25 
12 High risk for 
T2D 
155 12 Diet, PA, weight 
reduction 
Wide range 
Asian ethnicity 
Snehalatha 
(2008)34 
RCT India Indian 35-
55 
79 High risk for 
T2D 
531 36 Diet, PA, medication Secondary 
analysis / 
cohort study 
Snehalatha 
(2009)37 
RCT India Indian 35-
55 
79 High risk for 
T2D 
437 36 Diet, PA, medication Secondary 
analysis / 
cohort study 
Ramachandran 
(2010)37 
RCT, but 
arms 
combined 
India Indian 35-
55 
83 High risk for 
T2D 
845 36 Diet, PA Secondary 
analysis 
Patel (2011)37 RCT UK South 
Asian 
<55 - High risk for 
T2D 
50 2 Diet (low Glycemic 
Index components) 
No results 
reported 
Ram (2014)38 RCT, but 
arms 
combined 
India Indian 35-
55 
100 High risk for 
T2D 
537 24 Diet, PA Secondary 
analysis / 
cohort study 
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Weber (2016)39 RCT India Indian 20-
65 
63 High risk for 
T2D 
578 36 Diet, PA, medication No identifiable 
subgroup 
without 
medication 
use 
Willis (2016)40 Feasibility 
study 
UK Punjabi, 
Sikh and 
Gujarati 
Hindu 
35-
75 
49 High risk for 
T2D 
202 - PA (walking) No results 
reported 
Patel (2017)41 RCT US Asian 
Indians 
> 18 44 High risk for 
T2D 
70 3+3 Diet, PA Considered of 
weak quality, 
see Suppl. 
table 2 
Wijesuriya 
(2017)42 
RCT Sri 
Lanka 
Sri Lankan 6-40 48 Risk factors for 
T2D 
4672 36 Diet, PA, weight 
education, stress 
reduction 
No non-
lifestyle 
intervention 
control group 
Thankappan 
(2018)32 
Cluster-
RCT 
India Indian 30-
60 
47 High risk for 
T2D 
1007 24 Diet, PA, weight 
maintenance, tobacco 
cessation, reducing 
alcohol, adequate sleep 
Published after 
date of 
inclusion into 
IPD 
* Duration in months, RCT: Randomised controlled study, PA: Physical activity,  
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ESM Table 2.   Quality assessment of potentially eligible studies 
 
Study ID/year Selection Bias Design Confounders Blinding Data 
Collection 
Drop-Outs Overall 
rating* 
Included 
IDPP-1 (2006)12 2 1 1 2 1 1 Strong Yes 
PAMH (2012)18 1 1 1 2 1 1 Strong Yes 
InnvaDiabDE-PLAN (2013)17 1 1 1 3 1 1 Moderate Yes 
DHIAAN (2013)15 2 1 1 2 1 2 Strong Yes 
Indian SMS Study (2013)26 1 1 1 2 1 1 Strong Yes 
PODOSA (2014)16 1 1 1 2 1 1 Strong Yes 
Patel 201741 3 1 1 2 1 3 Weak No 
 
* The Quality Assessment Tool for Quantitative Studies23 developed by the Effective Public Health Practice Project was used. Rating: 1= strong, 2 = moderate, 3 
= weak. The quality assessment for DHIAAN was based on published paper for results after 12 months, but in the present paper we use 2 year data.  
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ESM Table 3. Lost to follow-up by study duration 
 
  Total Intervention Control 
IDDP-112 Baseline 253 120 133 
 1 year 253 120 133 
 Lost to follow-up (n) 0 0 0 
 Lost to follow-up (%) 0 0 0 
 
2 year 253 120 133 
 Lost to follow-up (n) 0 0 0 
 Lost to follow-up (%) 0 0 0 
 3 year 253 120 133 
 Lost to follow-up (n) 0 0 0 
 Lost to follow-up (%) 0 0 0 
PAMH18 Baseline 139 85 54 
 5 months 120 73 47 
 Lost to follow-up (n) 19 12 7 
 Lost to follow-up (%) 13.7 14.1 13.0 
InnvaDiab-
DEPLAN17 
Baseline 180 92 88 
 7 months 139 71 68 
 Lost to follow-up (n) 41 21 20 
 Lost to follow-up (%) 22.8 22.8 22.7 
DHIAAN15 Baseline 536 283 253 
 1 year 340 179 161 
 Lost to follow-up (n) 190 101 89 
 Lost to follow-up (%) 35.8 36.1 35.6 
 2 year 324 167 157 
 Lost to follow-up (n) 206 113 93 
 Lost to follow-up (%) 38.9 40.4 37.2 
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Indian SMS 
study26 
Baseline 537 271 266 
 1 year 494 250 244 
 Lost to follow-up (n) 43 21 22 
 Lost to follow-up (%) 8.0 7.7 8.3 
 2 year 476 246 230 
 Lost to follow-up (n) 61 25 36 
 Lost to follow-up (%) 11.4 9.2 13.5 
PODOSA16 Baseline 171 85 86 
 1 year 169 84 85 
 Lost to follow-up (n) 2 1 1 
 Lost to follow-up (%) 1.2 1.2 1.2 
 2 year 167 83 84 
 Lost to follow-up (n) 4 2 2 
 Lost to follow-up (%) 2.3 2.4 2.3 
 3 year 167 84 83 
 Lost to follow-up (n) 4 1 3 
 Lost to follow-up (%) 2.3 1.2 3.5 
Numbers are based on those randomized at inclusion  
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ESM Table 4. Baseline participant characteristics  
 
  N Intervention, 
mean (SD) 
N Control, 
mean (SD) 
Differences 
IDDP-112      
Weight (kg)  120 67.9 (10.19) 133 69.5 (10.42) -1.6 
Waist (cm) 120 88.9 (8.6) 133 89.7 (8.23) -0.8 
Body mass index (BMI) 120 25.7 (3.4) 133 26.3 (3.67) -0.60 
Fasting glucose 
(mmol/l) 
120 5.4 (0.72) 133 5.5 (0.78) -0.1 
2-hr glucose (mmol/l) 120 8.5 (0.71) 133 8.6 (0.75) -0.1 
Age (years) 120 45.9 (5.85) 133 45.2 (5.64) 0.7 
Women (%) 27 22.5 33 24.8 -2.3 
Men (%) 93 77.5 100 75.2 2.3 
      
PAMH18      2.20 
Weight (kg)  85 83.7 (12.04) 54 83.7 (13.76) 0.00 
Waist (cm) 85 97.7 (8.83) 54 98.6 (11.30) -0.90 
Body mass index (BMI) 85 27.08 (3.20) 54 27.2 (4.12) -0.12 
Fasting glucose 
(mmol/l) 
84 5.2 (0.39) 53 5.2 (0.42) 0.00 
2-hr glucose (mmol/l) 85 6.1 (1.59) 54 6.5 (1.72) -0.40 
Age (years) 84 35.6 (5.89) 54 39.2 (9.11) -3.60 
Men (%) 85 100 54 100 0 
      
InnvaDiab-DEPLAN17       
Weight (kg)  92 72.6 (14.04) 88 75.25 (14.69) -2.65 
Waist (cm) 90 94.8 (13.33) 88 96.1 (11.38) -1.30 
Body mass index (BMI) 92 29.1 (5.70) 88 29.7 (5.70) -0.60 
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Fasting glucose 
(mmol/l) 
92 5.2 (0.52) 87 5.1 (0.42) 0.10 
2-hr glucose (mmol/l) 91 6.5(1.79) 85 6.3 (1.14) 0.20 
Age (years)) 92 40.1 (7.63) 88 41.3 (8.16) -1.2 
Women (%  100  100 0 
      
DHIAAN15       
Weight (kg)  280 75.2 (13.60) 250 75.1 (13.91) 0.1 
Waist (cm) 279 92.6 (10.73) 249 93.0 (11.07) -0.40 
Body mass index (BMI) 280 27.7 (4.03) 250 27.7 (4.23) 0.00 
Fasting glucose 
(mmol/l) 
282 5.3 (0.55) 252 5.3 (0.51) 0.00 
2-hr glucose (mmol/l) 278 6.1 (1.65) 245 5.9 (1.69) 2.69 
Age (years) 283 43.6 (10.97) 253 43.5 (9.70) 2.7 
Women (%) 147 51.9 124 49.21 0.21 
Men (%) 136 48.1 128 50.79 -2.69 
      
Indian SMS study26      
Weight (kg)  271 72.3 (10.04) 266 71.8 (9.44) 0.5 
Waist (cm) 271 92.5 (7.07) 266 92.6 (7.31) -0.1 
Body mass index (BMI) 271 25.8 (3.30) 266 25.8 (2.99) 0.00 
Fasting glucose 
(mmol/l) 
271 5.6 (0.53) 266 5.5 (0.55) -0.1 
2-hr glucose (mmol/l) 271 8.7 (0.78) 266 8.8 (0.85) -0.1 
Age (years) 271 45.9 (4.77) 266 46.1 (4.62) -0.2 
Men (%) 271 100 266 100 0 
      
PODOSA16       
Weight (kg)  85 79.8 (16.23) 86 80.7 (14.98) -0.90 
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Waist (cm) 85 102.7 (11.15) 86 103.3 (11.01) -0.60 
Body mass index (BMI) 85 30.6 (5.02) 86 30.5 (4.60) 0.10 
Fasting glucose 
(mmol/l) 
85 5.8 (0.61) 86 5.8 (0.61) 0.00 
2-hr glucose (mmol/l) 85 8.2 (1.63) 86 8.3 (1.50) -0.10 
Age (years) 85 52.6  86 52.2 -0.40 
Women (%) 46 54.1 47 54.7 -0.60 
Men (%) 39 45.9 39 45.4 0.50  
Note: Data are n (%) or mean (SD) unless otherwise specified. Numbers are based on those randomized at inclusion with 
valid measurements on the respective variables.  
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ESM Table 5. Effects of lifestyle interventions (mean difference) on secondary outcomes by subgroups 
 
Outcome 
Stu-
dies 
(N) 
Participa
nts, N 
Interven
tion/Con
tol 
Intervention 
Mean 
(SD) Kg 
Control 
Mean 
(SD) Kg 
Summary 
Adjusted MD* 
(95% CI) 
P** I2 
(%) 
P inter-
action*** 
Sex       
Fasting glucose (mmol/l)       
Men 5 495/466 5.6 (0.91) 5.7 (1.25) -0.06 (-0.19, 0.08) 0.43 45 0.93 
Women 4 232/217 5.3 (0.82) 5.4 (0.89) -0.05 (-0.15, 0.05) 0.35 0  
2-hr glucose (mmol/l)       
Men 5 514/477 7.7 (2.51) 8.4 (3.21) -0.47 (-0.85, -
0.09) 
0.02 51 0.36 
Women 4 229/207 6.7 (2.15) 7.2 (2.65) -0.22 (-0.58, 0.13) 0.22 18  
Weight (kg)        
Men 5 526/495 74.9 (12.56) 75.1 
(12.14) 
-1.05 (-1.98 -0.12) 0.03 81 0.26 
Women 4 235/222 71.2 (13.85) 71.9 
(12.83) 
-0.43 (-0.97, 0.11) 0.12 0  
Waist (cm)        
Men 5 519/486 93.7 (9.35) 94.3 (9.21) -1.22 (-2.49, 0.04) 0.06 79 0.78 
Women 4 235/221 93.8 (11.83) 94.7 
(10.82) 
-1.00 (-1.92, -
0.08) 
0.03 0  
         
BMI groups         
Fasting glucose (mmol/l) 
≥ 27.5 
kg/m2 
6 359/355 5.4 (0.85) 5.5 (1.05) -0.03 (-0.17, 0.12) 0.19 33 0.79 
<27.5 
kg/m2 
6 368/329 5.6 (0.92) 5.8 (1.24) -0.03 (-0.11, 0.05) 0.48 0  
2-hr glucose (mmol/l)   
≥ 27.5 
kg/m2 
6 358/349 6.8 (2.28) 7.4 (2.9) -0.22 (-0.70, 0.25) 0.35 52 0.75  
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<27.5 
kg/m2 
6 385/336 7.9 (2.49) 8.7 (3.15) -0.31 (-0.54, -
0.08) 
0.008 1  
Weight (kg)         
≥ 27.5 
kg/m2 
6 374/372 79.7 (14.40) 79.7 
(13.25) 
-0.96 (-1.71 -0.21) 0.01 46 0.53 
<27.5 
kg/m2 
6 387/346 68.0 (8.26) 68.2 (8.02) -0.66 (-1.24, -
0.08) 
0.02 56  
Waist (cm)         
≥ 27.5 
kg/m2 
6 370/366 98.5 (11.17) 98.6 
(10.46) 
-1.13 (-2.42, 0.16) 0.09 54 0.57 
<27.5 
kg/m2 
6 384/342 89.1 (6.35) 90.0 (6.42) -0.95 (-1.84, -
0.06) 
0.04 53  
         
Age         
Fasting glucose (mmol/l) 
>44 years  6 399/382 5.6 (0.86) 5.7 (1.05) -0.08 (-0.18, 0.02) 0.14 0 0.38 
≤ 44 years 6 328/302 5.4 (0.92) 5.5 (1.26) -0.00 (-0.14, 0.14) 0.99 46  
2-hr glucose (mmol/l)  
>44 years  6 405/389 7.6 (2.41) 8.1 (3.02) -0.39 (-0.78, 0.00) 0.05 47 0.66 
≤ 44 years 6 338/296 7.1 (2.47) 7.9 (3.19) -0.27 (-0.60, 0.05) 0.10 29  
Weight (kg)         
>44 years  6 415/402 72.5 (12.36) 73.2 
(11.98) 
-0.79 (-1.45, -
0.13) 
0.02 57 0.61 
≤ 44 years 6 346/316 75.2 (13.76) 75.3 
(12.93) 
-0.52 (-1.34, 0.31) 0.22 66  
Waist (cm)         
>44 years  6 413/396 94.3 (9.79) 94.7 (9.40) -0.55 (-1.49, 0.40) 0.26 46 0.34 
≤ 44 years 6 341/312 93.0 (10.60) 94.1 
(10.14) 
-1.36 (-2.73, 0.01) 0.05 71  
 
Study duration 
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Fasting glucose (mmol/l) 
5-7 months 2 142/114 5.2 (0.53) 5.2 (0.48) -0.04 (-0.14, 0.06) 0.44 0 0.81 
2-3 years 4 585/570 5.6 (0.95) 5.7 (1.23) -0.06 (-0.23, 0.09) 0.41 56  
2-hr glucose (mmol/l)  
5-7 months 2 138/106 5.7 (1.50) 6.0 (1.59) -0.12 (-0.53, 0.28) 0.55 31 0.22 
2-3 years 4 605/579 7.8 (2.46) 8.4 (3.16) -0.47 (-0.86, -
0.09) 
0.01 56  
Weight (kg)         
5-7 months 2 144/115 77.6 (13.87) 77.9 
(14.17) 
-1.22 (-2.23, -
0.18) 
0.02 64 0.39 
2-3 years 4 617/603 72.8 (12.73) 73.4 
(11.97) 
-0.54 (-1.23, 0.14) 0.12 71  
Waist (cm)         
5-7 months 2 143/114 95.5 (11.54) 97.2 
(10.57) 
-2.17 (-4.57, 0.22) 0.08 84 0.24 
2-3 years 4 611/594 93.3 (9.80) 93.9 (9.48) -0.66 (-1.51, 0.18) 0.12 50  
 
Study region 
Fasting glucose (mmol/l) 
Europe 4 388/347 5.2 (0.73) 5.3 (0.85) -0.05 (-0.13, 0.03) 0.25 0 0.71 
India 2 339/337 5.8 (0.96) 6.0 (1.32) -0.13 (-0.59, 0.32) 0.56 83  
2-hr glucose (mmol/l)  
Europe 4 378/329 6.1 (1.95) 6.6 (2.24) -0.22 (-0.46, 0.01) 0.07 2 0.40 
India 2 365/356 8.7 (2.24) 9.4 (3.18) -0.69 (-1.74, 0.36) 0.20 84  
Weight (kg)         
Europe 4 395/355 76.6 (14.65) 77.0 
(13.90) 
-1.10 (-1.66, -
0.54) 
0.0001 42 0.02 
India 2 366/363 70.6 (10.28) 71.3 
(10.08) 
-0.08 (-0.75, 0.58) 0.81 50  
Waist (cm)         
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Europe 4 394/354 95.8 (11.43) 96.9 
(10.92) 
-1.59 (-2.94, -
0.27) 
0.02 75 0.09 
India 2 360/354 91.4 (8.01) 92.0 (7.64) -0.26 (-1.00, 0.47) 0.46 0  
 
*Model based on pooled data with last estimate (Podosa and IDDP =3 years, DHIAAN and Indian SMS Study = 2 years, 
InnvaDiab = 7 months and PAMH= 5 months), adjusted for age and baseline values for outcome variable. ** P values for 
mean difference, p values < 0.05 in bold. *** P values for interaction term for subgroup analyses, p values < 0.05 in bold 
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ESM Figure 1. Flow Diagram   
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ESM Figure 2. Effects (mean difference) for secondary continuous outcomes  
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A. Fasting Glucose 
 
B. 2-hour glucose 
 
ESM Figure 3. Distribution curves at last follow-up for all studies merged 
 
